News Headlines Article

Generic drug industry needs to stand up for patient safety
Los Angeles Times

The Generic Pharmaceutical Assn. says a proposed federal regulation that would allow makers of generic drugs to inform people about all known health risks would create “dangerous confusion” and have “harmful consequences for patients.” And why would that be? For the answer, the industry group pointed me toward a recent report from Matrix Global Advisors, an independent consulting firm.

Commands